You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,478,601


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,478,601 protect, and when does it expire?

Patent 10,478,601 protects JUBLIA and is included in one NDA.

This patent has twenty patent family members in fifteen countries.

Summary for Patent: 10,478,601
Patent landscape, scope, and claims:
Title:Applicator
Abstract: To provide a solution applicator with which irritation on an affected part of a patient may be reduced even when a solution is used. According to the present invention, an applicator comprises a solution container which comprises an opening, and a columnar brush member formed by bundling synthetic fibers in a columnar shape. The columnar brush member is disposed at the opening of the solution container, a tip portion of the columnar brush member at an outside of the solution container has a fan shape expanding in a perpendicular lateral direction against a pillar axial lengthwise direction, and a thickness of the fan-shaped tip portion of the columnar brush member decreases in a perpendicular lengthwise direction against the pillar axial lengthwise direction toward the tip portion of the columnar brush member. The solution applicator of the present invention has the fan-shaped tip portion so that irritation on an affected part may be decreased and a liquid tinea unguium medicine may be applied to the affected part.
Inventor(s): Ueta; Masahiro (Bunkyo-ku, JP), Sakaguchi; Ryouhei (Ichinomiya, JP), Takei; Ryouji (Souka, JP), Sasama; Katsumi (Sumida-ku, JP), Taguchi; Katsuya (Chiyoda-ku, JP)
Assignee: KAKEN PHARMACEUTICAL CO., LTD. (Tokyo, JP)
Application Number:14/130,822
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,478,601
Patent Claim Types:
see list of patent claims
Use; Formulation; Delivery;

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,478,601

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch JUBLIA efinaconazole SOLUTION;TOPICAL 203567-001 Jun 6, 2014 AB RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y TOPICAL TREATMENT OF TINEA UNGUIUM BY USING AN APPLICATOR FOR APPLYING A SOLUTION FOR TREATING TINEA UNGUIUM TO AN AFFECTED PART OF A PATIENT ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 10,478,601

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan2011-149605Jul 5, 2011
PCT Information
PCT FiledJuly 04, 2012PCT Application Number:PCT/JP2012/004352
PCT Publication Date:January 10, 2013PCT Publication Number: WO2013/005434

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.